First Light Asset Management, LLC Centessa Pharmaceuticals PLC Transaction History
First Light Asset Management, LLC
- $1.15 Billion
- Q3 2024
A detailed history of First Light Asset Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, First Light Asset Management, LLC holds 5,940,132 shares of CNTA stock, worth $101 Million. This represents 8.27% of its overall portfolio holdings.
Number of Shares
5,940,132
Previous 4,780,560
24.26%
Holding current value
$101 Million
Previous $43.2 Million
120.03%
% of portfolio
8.27%
Previous 3.93%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$338 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$169 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$106 Million2.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.68MShares$79.3 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...